MFDS’s active support on developing orphan drugs for Korean pharmas

Published: 2017-05-09 13:30:35

Updated: 2017-05-09 13:30:35

The Ministry of Food and Drug Safety(MFDS) will make various systematic support plans to promote Korean pharmaceutical companies to expand their business into the orphan drug market which globally records a high 10% growth rate.

According to the Korea Health Industry Development Institute(KHDI), the global orphan drug market is rapidly growing with an annual average 11.4% rate, and is expected...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.